Literature DB >> 11201468

TI-201 SPECT compared with histopathologic grade in the prognostic assessment of cerebral gliomas.

T Higa1, S Maetani, K Yoichiro, S Nabeshima.   

Abstract

PURPOSE: Although TI-201 SPECT has been used to evaluate the malignant grade of cerebral gliomas, the gold standard continues to be histopathologic examination. The authors assessed and compared the prognostic abilities of the two studies using survival analysis.
MATERIALS AND METHODS: Twenty-nine patients underwent 34 sessions of TI-201 SPECT plus surgery for primary or recurrent cerebral gliomas 12 to 78 months before this analysis. Using conventional survival analyses, such as the log-rank test, Cox regression, and the Akaike cross-tab method, the authors evaluated the prognostic significance of 10 variables: histopathologic grade, TI-201 SPECT, Tc-99m HMPAO SPECT, tumor cell viability, radionecrosis, neurologic defects, clinical improvement, surgery, chemotherapy, and external beam radiotherapy.
RESULTS: TI-201 SPECT was most strongly related to prognosis, followed by histopathologic grade. The other variables had little prognostic value. The Cox stepwise selection procedure indicated that TI-201 SPECT was the only independent predictor of outcome, whereas histopathologic analysis was eliminated from the prognostic model. However, the Kaplan-Meier survival curve and the Akaike method indicated that histopathologically low-grade tumors were more closely associated with longer-term survival than were TI-201 low uptake tumors.
CONCLUSIONS: TI-201 SPECT is not only closely correlated with the histopathologic grade of tumor but is a significantly better predictor of outcome than histopathologic grade. However, histopathologic examination may provide additional information on longer-term survival. TI-201 SPECT is a valuable procedure, especially in patients in whom a histologic diagnosis of possible glioma cannot be made.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11201468     DOI: 10.1097/00003072-200102000-00006

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

1.  Clinical significance of thallium-201 SPECT after postoperative radiotherapy in patients with glioblastoma multiforme.

Authors:  Gyo Iida; Kazuhiko Ogawa; Shogo Ishiuchi; Itaru Chiba; Takashi Watanabe; Naofumi Katsuyama; Yoshihiko Yoshii; Sadayuki Murayama
Journal:  J Neurooncol       Date:  2010-09-02       Impact factor: 4.130

2.  Thallium-201SPECT assessment in the detection of recurrences of treated gliomas and ependymomas.

Authors:  Ana Paula Caresia; Joan Castell-Conesa; Montserra Negre; Antoni Mestre; Gemma Cuberas; Anabel Mañes; Xavier Maldonado
Journal:  Clin Transl Oncol       Date:  2006-10       Impact factor: 3.405

Review 3.  Techniques to assess the proliferative potential of brain tumors.

Authors:  Alfredo Quiñones-Hinojosa; Nader Sanai; Justin S Smith; Michael W McDermott
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

4.  Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.

Authors:  C Walker; B Haylock; D Husband; K A Joyce; D Fildes; M D Jenkinson; T Smith; J Broome; K Kopitzki; D G du Plessis; J Prosser; S Vinjamuri; P C Warnke
Journal:  Br J Cancer       Date:  2006-10-10       Impact factor: 7.640

5.  Differential diagnosis of posterior fossa brain tumors: Multiple discriminant analysis of Tl-SPECT and FDG-PET.

Authors:  Moritaka Yamauchi; Tomohisa Okada; Tsutomu Okada; Akira Yamamoto; Yasutaka Fushimi; Yoshiki Arakawa; Susumu Miyamoto; Kaori Togashi
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.